0001950047-23-005847.txt : 20231211
0001950047-23-005847.hdr.sgml : 20231211
20231211161613
ACCESSION NUMBER: 0001950047-23-005847
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231211
DATE AS OF CHANGE: 20231211
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 231478326
BUSINESS ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dorling Janet
CENTRAL INDEX KEY: 0001738144
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O ACHAOGEN, INC.
STREET 2: 1 TOWER PLACE, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
144
1
primary_doc.xml
144
0001738144
XXXXXXXX
LIVE
0001042074
CYMABAY THERAPEUTICS, INC.
001-36500
7575 Gateway Blvd, Suite 110
Newark
CA
94560
(510) 293-8800
JANET DORLING
Director
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
38th Floor
New York
NY
10004
6000
120421.80
113403353
12/11/2023
NASDAQ
COMMON
12/11/2023
Stock Option Exercise
ISSUER
N
6000
12/11/2023
Cash
N
JANET DORLING
7575 Gateway Blvd, Suite 110
Newark
CA
94560
Common
11/10/2023
7000
106699.60
12/11/2023
08/09/2023
/s/ Janet Dorling